0000899243-21-018420.txt : 20210505 0000899243-21-018420.hdr.sgml : 20210505 20210505194752 ACCESSION NUMBER: 0000899243-21-018420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210503 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carey John F CENTRAL INDEX KEY: 0001774272 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 21895211 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD STREET 2: SUITE 302 CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-03 0 0001756262 TransMedics Group, Inc. TMDX 0001774272 Carey John F C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 0 1 0 0 VP of Operations Common Stock 2021-05-03 4 M 0 702 16.14 A 702 D Common Stock 2021-05-03 4 M 0 978 2.21 A 1680 D Common Stock 2021-05-03 4 S 0 1380 28.22 D 300 D Common Stock 2021-05-03 4 S 0 300 28.87 D 0 D Stock Option (Right to Buy) 16.14 2021-05-03 4 M 0 702 0.00 D 2030-02-27 Common Stock 702 10938 D Stock Option (Right to Buy) 2.21 2021-05-03 4 M 0 978 0.00 D 2027-06-22 Common Stock 978 22353 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $27.79 to $28.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $28.80 to $28.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. /s/ Stephen Gordon, Attorney-in-Fact 2021-05-05